Ying Dong
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Blood Coagulation and Thrombosis Mechanisms, Bioactive Compounds and Antitumor Agents, Peptidase Inhibition and Analysis, Cancer therapeutics and mechanisms
Most-Cited Works
- → Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases(2013)604 cited
- → An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone(2007)347 cited
- → Superparamagnetic Iron Oxide Nanoparticles: Amplifying ROS Stress to Improve Anticancer Drug Efficacy(2013)315 cited
- → The Tissue Kallikrein Family of Serine Proteases: Functional Roles in Human Disease and Potential as Clinical Biomarkers(2004)218 cited
- → IL‐10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF‐κB/Notch1 pathway in non‐small cell lung cancer(2019)165 cited
- → β-Lapachone-containing PEG–PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells(2007)160 cited
- → The Expanded Human Kallikrein (KLK) Gene Family: Genomic Organisation, Tissue-Specific Expression and Potential Functions(2001)152 cited
- → An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis(2012)141 cited
- → Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors(2016)130 cited
- → Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs)(2008)129 cited